Growth Metrics

ProQR Therapeutics (PRQR) Net Income towards Common Stockholders (QoQ) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 ProQR Therapeutics 174.11 Mn 66.54 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 29.18%
Sep 30, 2025 11.43%
Jun 30, 2025 -32.44%
Mar 31, 2025 -11.76%
Dec 31, 2024 -5.55%
Sep 30, 2024 -221.44%
Jun 30, 2024 65.15%
Mar 31, 2024 -56.65%
Dec 31, 2023 19.29%
Sep 30, 2023 24.39%
Jun 30, 2023 11.40%
Mar 31, 2023 27.59%
Dec 31, 2022 42.30%
Sep 30, 2022 -60.83%
Jun 30, 2022 7.68%
Mar 31, 2022 24.03%
Dec 31, 2021 -17.47%
Sep 30, 2021 7.25%
Jun 30, 2021 -25.81%
Mar 31, 2021 4.98%
Dec 31, 2020 -1.97%
Sep 30, 2020 -235.50%
Jun 30, 2020 73.61%
Mar 31, 2020 13.61%
Dec 31, 2019 -51.88%
Sep 30, 2019 -3.18%
Jun 30, 2019 18.64%
Mar 31, 2019 -8.91%
Dec 31, 2018 -113.16%
Sep 30, 2018 20.90%
Jun 30, 2018 -67,013.44%
Mar 31, 2018 -99.90%
Dec 31, 2017 107,461.12%
Sep 30, 2017 100.10%
Jun 30, 2017 -211.90%
Mar 31, 2017 217.26%
Dec 31, 2016 15.76%
Sep 30, 2016 -0.45%
Jun 30, 2016 -15.78%
Mar 31, 2016 -44.73%
Dec 31, 2015 4.43%
Sep 30, 2015 26.28%
Jun 30, 2015 92.77%
Mar 31, 2015 -5,077.93%
Dec 31, 2014 43.17%
Mar 31, 2014 -14.36%
Dec 31, 2013 -91.60%